News List

New policy by the American College of Physicians opposes the term "provider" for physicians

Labeling physicians as providers reduces the patient–physician relationship to a commercial transaction

The FDA has approved a new medication for pain

The last approved medication was pregabalin, over 20 years ago

The New York Times publishes an extensive article on chronic pain

Chronic Pain Is a Hidden Epidemic, It’s Time for a Revolution, By Jennifer Kahn

The NIH funds our 2-year training program in clinical pain research

This supplement to existing HEAL clinical research awards funds the training of early career individuals in clinical pain research. Our trainee is Abby Chiu.

We are starting the research project: "Metabolomics profiles of chronic low back pain and fibromyalgia"

Collaborator: Merck & Co., Inc

The NIH funds our large project on the mechanisms of human pain

A collaboration with Ted Price (University of Texas at Dallas), Pat Dougherty (MD Anderson Cancer Center), and Christoph Hofstetter (University of Washington)

The Lancet Rheumatology publishes our review

Central sensitization in chronic pain conditions

Publication of our paper in Neuron

A proposal for multi-institutional efforts to understand the human neurobiology of pain and identify therapeutic targets

The NIH approves funding for our 5-year project on neck pain

We use RNA sequencing from neck tissues and advanced phenotyping to identify new treatment targets for chronic pain.

Excellent point of view in JAMA: The term “provider” should not be used

Beasley JW, Roberts RG, Goroll AH. Promoting Trust and Morale by Changing How the Word Provider Is Used: Encouraging Specificity and Transparency. JAMA. 2021;325(23):2343–2344. doi:10.1001/jama.2021.6046